SCHEMBL16596972

SCHEMBL16596972

Cc1cccc2nc(C)n(-c3ccc(F)cc3)c(=O)c12

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 7/20 0.56
KCNH2 Q12809 4/20 0.56
POLB P06746 2/20 0.56
HKDC1 Q2TB90 1/20 0.52
HDAC1 Q13547 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
MAPK1 P28482 1/20 0.46
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
TSHR P16473 2/20 0.45
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
PIK3CD O00329 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
GLA P06280 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16596948 0.87 HDAC1 (0.57) HRH3KCNH2POLBHKDC1HDAC1
SCHEMBL30726108 0.87 HDAC1 (0.57) HRH3KCNH2POLBHKDC1HDAC1
SCHEMBL16596959 0.86 HRH3 (0.57) HRH3KCNH2POLBHKDC1HDAC1
SCHEMBL16596950 0.86 PIK3CD (0.52) HRH3KCNH2POLBHDAC1HDAC8
SCHEMBL28924700 0.86 HRH3 (0.56) HRH3KCNH2POLBHDAC1HDAC8
SCHEMBL16596931 0.81 PIK3CD (0.49) HRH3KCNH2PIK3CDL3MBTL1GLA
SCHEMBL16596955 0.80 PIK3CD (0.57) HRH3KCNH2TSHRPIK3CDL3MBTL1
SCHEMBL15870130 0.79 PIK3CD (0.47) HRH3KCNH2PIK3CD
SCHEMBL16596952 0.78 HRH3 (0.57) HRH3KCNH2POLBHKDC1HDAC1
SCHEMBL28924734 0.78 HRH3 (0.57) HRH3KCNH2POLBHKDC1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9518046-B2 Substituted aminopyrimidine compounds and methods of use CALITOR SCIENCES, LLC (US) 2016-12-13 US disclosed
US-20160318913-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-11-03 US disclosed
US-20150087663-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE SUNSHINE LAKE PHARMA CO., LTD. (CN) 2015-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150087663-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE PIK3CA, PIK3CD, MYD88 HRH3 2135/4885KCNH2 4020/4885POLB 434/4885
US-20160318913-A1 SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE PIK3CA, PIK3CD, MYD88 HRH3 2067/4885KCNH2 4078/4885POLB 426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.